Taking Biobased Industries to the next level: EFIB’s record growth

05.10.2012

Taking Biobased Industries to the next level: EFIB’s record growth demonstrates the biobased economy translating potential into commercial success

 
This year EuropaBio, Smithers Rapra and CLIB2021 will deliver the largest ever EFIB, Europe’s premier event for the biobased industries, designed to bring together policy, business and innovation in this vital sector of Europe’s economy, taking place in Dusseldorf on 16-18 October.
 
With an anticipated attendance of 500 people, the show has grown considerably and is recognised as the market leading event. The delegate list combines the most important business and policy makers in the biobased economy and provides the opportunity to meet and discuss the essential issues that will shape the future.
 
‘With annual turnover of around 2 trillion Euro and employing around 22 million people, the bioeconomy is already one of Europe’s biggest and most important sectors. Its potential for further growth in the future is even greater’ stated Maire Geoghegan Quinn who will address the conference.
 
‘EFIB 2012 is a timely opportunity to consider the implementation of the biobased economy strategy announced earlier this year in the context of the CAP reform and the shaping of Horizon 2020, Europe’s research and innovation framework from 2014-2020’commented Joanna Dupont-Inglis , Director for Industrial Biotech at EuropaBio, adding ‘innovation and investment will be essential to ensure successful implementation of the EU Bioeconomy strategy. EFIB will showcase the latest and most important breakthroughs from new start up SME’s through to large multinational ventures’
 
The event brings together not only European but also international emerging markets like Malaysia and Russia to discuss collaborations from across the value chain with feedstock companies through to consumer product giants using biobased technologies such as Unilever and Coca Cola.
 
Lars Hansen, Conference Chair and President, Novozymes Europe commented ‘EFIB’s impressive growth is indicative of the progress we have made as an industry and provides the perfect forum for the engagement of stakeholders required to deliver the biobased economy in Europe. The Ad Hoc session -Towards a Public Private Partnership on biobased industries will discuss how best to boost
our sector’s contribution to Europe’s economic recovery and long-term green growth and job creation objectives. ’
 
The Biobased industry is transforming Europe and changing the foundations of industry around the world. EFIB is the essential platform for monitoring, discussing and helping to drive this exciting process.
 
More info at www.efibforum.com
 
For further information please contact:
 
Natalie Findlay:
Phone: +44 1372 802104
 
OR
 
Rosalind Travers
Manager, Communications & National Associations
Phone: +32 (0) 2 739 1173
GSM: +32 (0) 478 680 301
Tags: